Literature DB >> 5044817

Pralidoxime methanesulfonate: plasma levels and pharmacokinetics after oral administration to man.

F R Sidell, W A Groff, A Kaminskis.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1972        PMID： 5044817     DOI： 10.1002/jps.2600610722

Source DB:  PubMed          Journal:  J Pharm Sci        ISSN： 0022-3549            Impact factor:   3.534


× No keyword cloud information.
  4 in total

Review 1.  Critical compilation of terminal half-lives, percent excreted unchanged, and changes of half-life in renal and hepatic dysfunction for studies in humans with references.

Authors:  L A Pagliaro; L Z Benet
Journal:  J Pharmacokinet Biopharm       Date:  1975-10

2.  Plasma concentrations of the oxime Pralidoxime Mesylate (P2S) after repeated oral and intramuscular administration.

Authors:  P Holland; D C Parkes
Journal:  Br J Ind Med       Date:  1976-02

3.  Administration of obidoxime tablets to man. Plasma levels and side reactions.

Authors:  G A Simon; M S Tirosh; H Edery
Journal:  Arch Toxicol       Date:  1976-09-15       Impact factor: 5.153

4.  Plasma concentrations of pralidoxime methylsulphate in organophosphorus poisoned patients.

Authors:  J L Willems; J P Langenberg; A G Verstraete; M De Loose; B Vanhaesebroeck; G Goethals; F M Belpaire; W A Buylaert; D Vogelaers; F Colardyn
Journal:  Arch Toxicol       Date:  1992       Impact factor: 5.153
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.